Tetracycline-derivatives as inhibitors of dengue virus type 2
碩士 === 國立交通大學 === 生物科技系所 === 95 === The WHO has estimated there are about 50 million dengue cases each year globally. Currently there is no commercial available vaccine and treatment. In previous study, this laboratory has obtained a list of compound candidates by applying virtual screening based on...
Main Authors: | Yu-Yin Tu, 杜育穎 |
---|---|
Other Authors: | Yun-Liang Yang |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/59728339150759764225 |
Similar Items
-
Defining the Functional Components of Tetracycline-derived Dengue Virus Type 2 Inhibitor
by: Liu, Ching-Hung, et al.
Published: (2011) -
Functional Expression of NS2 & NS4 of Dengue Virus 2 and Mechanism Study of Tetracycline-Derivatives as Dengue Virus Inhibitors
by: Chang, Ching-Yun, et al. -
The effect of tetracycline derivatives on dengue virus type II and Japanese encephalitis virus in C6/36 and 293T
by: Huang, Ching-Chun, et al.
Published: (2011) -
Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors.
by: Jinn-Moon Yang, et al.
Published: (2007-01-01) -
Effects of Tetracycline Derivatives on Dengue Virus serotype II PL046 Strain and Japanese encephalitis virus RP9 Strain
by: Yu, Ching, et al.
Published: (2013)